Holyrab 20 Tablet contains Rabeprazole 20 mg, a proton pump inhibitor (PPI) used to reduce gastric acid secretion. It is primarily indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, and peptic ulcer disease. Rabeprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing the final step of acid production. This results in decreased gastric acidity, promoting ulcer healing and symptom relief in acid-related disorders. Holyrab 20 is typically administered orally, once daily before meals, with dosage adjustments based on clinical response and specific indications. It is generally well tolerated; however, potential side effects may include headache, diarrhea, nausea, abdominal pain, and dizziness. Long-term use should be monitored due to risks such as vitamin B12 deficiency, hypomagnesemia, and increased susceptibility to gastrointestinal infections. Caution is advised in patients with hepatic impairment. Holyrab 20 should not be co-administered with drugs requiring acidic gastric pH for absorption without medical supervision. Patients are advised to follow prescribed dosing regimens and consult healthcare providers if adverse effects or inadequate symptom control occurs. This medication is a valuable option in managing acid-related gastrointestinal conditions effectively.

Dosage & How to Use